The stock currently trades at 2.7x Sep'24E ABV. We reiterate our BUY recommendation, valuing the stock at 3x Sep'24E ABV to the core book and a subsidiary value of Rs 187, to arrive at a target price of Rs 1,150/share, implying an upside of 30% from the CMP.